Improved patients compliance through use of a daily drug reminder chart.

Gabriel, Meghan Hufstader; Gagnon, Jean Paul; Bryan, Candace K.

doi:10.2105/ajph.67.10.968

Cited by 59 publications

(24 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Pharmacist interventions, such as the use of a drug reminder chart, 8 follow-up telephone calls, 9 and patient counseling, 10 can improve adherence. A critical review of medication adherence intervention by Haynes et al 11 suggested that compliance with short-term treatments can be improved by clear instructions, reminder pill containers, and calendars.…”

mentioning

confidence: 99%

A Randomized Controlled Trial of an Enhanced Patient Compliance Program for Helicobacter pylori Therapy

Lee¹,

Kemp²,

Canning³

et al. 1999

Arch Intern Med

View full text Add to dashboard Cite

Objectives:To determine whether an enhanced compliance program (ECP) improves patient compliance with bismuth subsalicylate, metronidazole, and tetracycline hydrochloride (BMT) triple therapy for the treatment of Helicobacter pylori infection and to identify factors that affect compliance with therapy.Design: A randomized controlled trial conducted in 4 staff-model health centers of a health maintenance organization in Massachusetts. Patients and Methods:A total of 125 patients 18 years of age or older with peptic ulcer disease or dyspepsia whose clinicians prescribed BMT triple therapy for 14 days were randomized to a control group or to the ECP group. The ECP group received medication counseling (written and oral) from a pharmacist, along with a medication calendar and a minipillbox, as well as a follow-up telephone call after initiation of therapy. Compliance was assessed by a pill count, and factors affecting adherence to the regimen were identified by patients' reports.Results: There was no statistically significant difference between the 2 groups in the number of patients taking more than 60% of the medications (89% of the control group vs 95% of the ECP group; PϾ.30). However, there was a statistically significant difference in the number of patients taking more than 90% of the medications (67% of the control group vs 89% of the ECP group; PϽ.01). An intention-to-treat analysis confirmed these results. The most frequently reported adverse effect was gastrointestinal intolerance. Other factors reported to affect compliance included the frequency of dosing and the number of pills.Conclusions: These findings suggest that although adverse effects were common, most patients were able to complete 60% or more of the 2-week regimen. An ECP further improved the percentage of medications taken.

show abstract

mentioning

confidence: 99%

A Randomized Controlled Trial of an Enhanced Patient Compliance Program for Helicobacter pylori Therapy

Lee¹,

Kemp²,

Canning³

et al. 1999

Arch Intern Med

View full text Add to dashboard Cite

show abstract

“…One study (Gabriel, Gagron, & Bryan, 1977) of geriatric hypertensive patients using daily drug reminder charts to reinforce verbal instructions found a significant increase in patient compliance; greater knowledge of drug use, dose, frequency of administration, and time interval; and higher compliance scores in those patients having a positive attitude toward the chart. In another study of written memory aids, Wardless and Davie (1977) examined patients receiving verbal directions only and verbal instructions with a tear-off calendar aid or a table identification card.…”

Section: Educational Interventionsmentioning

confidence: 99%

Medication Compliance and the Aged: An Educational Challenge

Skolnick

Eddy

Pierre

1984

Educational Gerontology

View full text Add to dashboard Cite

mentioning

confidence: 99%

“…Early studies examined the impact of CPs and reported improved outcomes with clinical pharmacy management of care on patient compliance, [2][3][4][5][6] diabetes, 7 patient-specific drug information, 8 and treatment of infections. 9 Systematic reviews of CP involvement in ambulatory settings note that while the quality of research (e.g., weak methodology, small sample sizes) is limited, the participation of CPs in health care has resulted in positive cost-effective care.…”

mentioning

confidence: 99%

Ambulatory Clinical Pharmacy Specialty Services: The Kaiser Permanente Colorado Experience

Hill¹,

Herner²,

Delate³

et al. 2014

JMCP

View full text Add to dashboard Cite

H ealth care in the United States is increasingly being delivered during ambulatory care visits. 1 As new investment in health care shifts from the inpatient to outpatient setting, the role of ambulatory clinical pharmacists (CP) are expanding. While dispensing pharmacists provide clinical screening and patient education for potential drugrelated problems, CPs provide services that complement the care provided by dispensing pharmacists by directly advising and educating other health care providers and patients on appropriate pharmaceutical use and dosing.Initial involvement of CPs in the ambulatory setting occurred primarily in the primary care setting. Early studies examined the impact of CPs and reported improved outcomes with clinical pharmacy management of care on patient compliance, [2][3][4][5][6] diabetes, 7 patient-specific drug information, 8 and treatment of infections.9 Systematic reviews of CP involvement in ambulatory settings note that while the quality of research (e.g., weak methodology, small sample sizes) is limited, the participation of CPs in health care has resulted in positive cost-effective care.10-12 A 2010 Cochrane review summarizing randomized controlled studies of CP involvement noted that most of the studies meeting inclusion took place in a primary care or community pharmacy setting rather than a specialties setting. 12CP involvement in ambulatory specialty areas has expanded into a broader array of disease states. Reports noting CP involvement in psychiatry practices were first published in the 1970s. 13,14 Currently, settings with CP involvement in specialty clinics include primarily health maintenance organizations, teaching institutions, and Veterans Affairs (VA) health systems.15 Other nonfee-for-service settings that may have specialty CP involvement include community clinics and other non-VA government health care systems. Systematic reviews summarizing the roles and/or impact of CP involvement in various specialty areas have been published. These areas include mental health, [16][17] 25 Knapp et al.'s (2005) 2004 survey of 233 ambulatory sites with CP involvement reported that the most common area of specialty CP involvement was oncology (28% of participating sites).15 Less than 10% of participating sites had CP involvement in neurology, heart failure, or psychiatry management, while involvement in other medical specialties was not reported by most participating sites.15 Accordingly, C O M M E N TA R YCP involvement in many specialties in the ambulatory setting has not been described in the literature, and little research on the clinical and economic outcomes of CP involvement has been conducted in specialty settings. [16][17][18]

show abstract

Improved patients compliance through use of a daily drug reminder chart.

Cited by 59 publications

References 5 publications

A Randomized Controlled Trial of an Enhanced Patient Compliance Program for Helicobacter pylori Therapy

A Randomized Controlled Trial of an Enhanced Patient Compliance Program for Helicobacter pylori Therapy

Medication Compliance and the Aged: An Educational Challenge

Ambulatory Clinical Pharmacy Specialty Services: The Kaiser Permanente Colorado Experience

Contact Info

Product

Resources

About